Table 2 The pathologic and operative outcomes
From: Segmental ureterectomy for high-risk ureteral carcinoma: a preliminary report
T stage | |
|---|---|
Ta T1 T2 T3 T4 | 12(60%) 1(5%) 5(25%) 2(10%) 0 |
N stage | 0 |
CIS | 0 |
Pathological grade | |
Low grade High grade | 10(50%) 10(50%) |
Estimated blood loss(ml) | |
Median Mean ± SD P25, P75 | 35.00 50.00 ± 10.13 20.00,50.00 |
Operation time(min) | |
Median Mean ± SD P25, P75 | 173.00 199.70 ± 69.9 149.25,255.00 |
Complication Grade | |
Clavien–Dindo I Clavien–Dindo II Clavien–Dindo III Clavien–Dindo IV Clavien–Dindo V None | 2(10%) 1(5%) 1(5%) 0 0 0 |
Biopsy before operation | |
Cytology Ureteroscopy None | 1(5%) 12(60%) 7(35%) |
Biopsy pathology | |
PUNLMP Low grade High grade NO defined NO | 5 4 2 2 7 |
Hospital Stay(Days) | |
Median Mean ± SD P25, P75 | 19.00 19.70 ± 1.56 14.25,23.25. |